4-Ethoxy-3-[3-(4-fluorophenyl)ureido]benzenesulfonyl chloride, 250mg

Cylinder Round Ø 70 mm in highest adjustable top layer of black glass and micrometer graduation of 0.01 mm. With wooden storage box

5-Iodo-1-methyl-1H-indazole, 95.0%, 250mg

Plan PLPHi 20x/0.40 phase contrast IOS infinity corrected objective

3-(4-Fluorophenyl)propan-1-ol, 95.0%, 1g

(5-Chloro-2-(2-(methylamino)thiazol-4-yl)pyridin-4-yl)(4-(4-chlorobenzyl)piperazin-1-yl)methanone, 98.0%, 1mg

5-Chlorosalicylaldehyde>98.0%(GC)(T)5g

BRETYLIUM TOSYLATE, 95%, 1mg

Methyl 3-bromobicyclo[1.1.1]pentane-1-carboxylate, 97%, 5g

[2,2':6',2''-Terpyridine]-4'-carboxylic acid, 95.0%, 100mg

3-Pyridinecarboxamide, N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-1,2-dihydro-2-oxo-, 98%, 50mg

Lithium(1+) 1-(4-chlorophenyl)-1H-imidazole-2-carboxylate, >95%, 1g

5-(Trifluoromethyl)benzo[c][1,2]oxaborol-1(3H)-ol, 98%, 1g